Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 15

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 15
---
incena S.A de C.V. SOFOM (“SOFOM”), Bioceres, UG Holdings, LLC (“UGH”) and Theo entered into an amended and restated loan agreement (the “SOFOM Loan”), pursuant to which SOFOM agreed to lend to Bioceres up to $1,500,000, which loan was secured by equity interests of Moolec Science SA and Bioceres Crop Solutions Corp. held by Bioceres, UGH and Theo. Amounts lent thereunder will be used by Bioceres to fund amounts lent to APx under the Bioceres Notes. As of March31, 2025, $1,500,000 has been drawn under the SOFOM Loan. Amounts outstanding under the SOFOM Loan will mature upon the earlier to occur of February26, 2026 or the date that is 30 days after the termination of the Lock -UpPeriod (as defined in the Registration Rights and Lock -UpAgreement). If APx does not complete an initial business combination, it is unlikely that Bioceres will recover funds drawn by APx under the BC Promissory Notes, which may be used to repay the SOFOM Loan. Conversely, if the Business Combination closes, APx will repay the BC Promissory Notes to Bioceres, which funds may be used repay the SOFOM Loan; •pursuant to the EarlyBird Engagement Letter, if the Business Combination closes, EarlyBird is entitled to the EarlyBird Fees, which consist of $2,000,000, up to $500,000 of which may be paid in Company Shares on the six -monthanniversary of the Closing; however, if the Closing does not occur, EarlyBird will not be entitled to the EarlyBird Fees; •the Sponsor is expected to hold an aggregate of approximately 9.5%, and the Initial Sponsor is expected to hold an aggregate of approximately 2.8%, of the outstanding Company Shares upon the consummation of the Business Combination, assuming no redemptions by Public Shareholders; •although there are no unreimbursed out -of -pocketexpenses as of March31, 2025, unless a business combination is consummated, members of the APx Board will not receive reimbursement for any out -of -pocketexpenses incurred by them on APx’s behalf incident to identifying, investigating, negotiating and completing a business combination to the extent such expenses exceed the amount not required to be retained in